DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
BMS-986020
2
Small molecule
Investigational
Unknown
Unknown
Idiopathic Pulmonary Fibrosis; Scleroderma, Localized
Lysophosphatidic acid receptor Edg-2 antagonist
BMS-986020
×
Maximum Phase:
2
First Approval:
None
UNII:
38CTP01B4L
Molecule Type:
Small molecule
Molecular Formula:
C29H26N2O5
Molecular Weight:
482.54
AlogP:
6.74
PSA:
101.66
HBD:
2.0
HBA:
#RotB:
7.0
Source:
GZ-389988
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Unknown
GZ-389988
×
Maximum Phase:
2
First Approval:
None
UNII:
XX8E5WP7FS
Molecule Type:
Small molecule
Molecular Formula:
C26H26N6O3
Molecular Weight:
470.53
AlogP:
4.06
PSA:
102.24
HBD:
1.0
HBA:
#RotB:
8.0
Source:
T-900607
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Liver Neoplasms; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Stomach Neoplasms
Tubulin disrupting agent
T-900607
×
Maximum Phase:
2
First Approval:
None
UNII:
IC9O2HT1X1
Molecule Type:
Small molecule
Molecular Formula:
C14H10F5N3O4S
Molecular Weight:
411.31
AlogP:
2.68
PSA:
110.52
HBD:
3.0
HBA:
#RotB:
5.0
Source:
LYSERGIDE
2
Small molecule
Investigational
Unknown
Unknown
Anxiety; Depressive Disorder, Major; Pain
Unknown
LYSERGIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
8NA5SWF92O
Molecule Type:
Small molecule
Molecular Formula:
C20H25N3O
Molecular Weight:
323.44
AlogP:
2.91
PSA:
39.34
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DEOXYANDROGRAPHOLIDE
2
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis, Chronic Progressive; Colorectal Neoplasms
Unknown
DEOXYANDROGRAPHOLIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
WLN91FAQ6Z
Molecule Type:
Small molecule
Molecular Formula:
C20H30O4
Molecular Weight:
334.46
AlogP:
2.99
PSA:
66.76
HBD:
2.0
HBA:
#RotB:
4.0
Source:
UK432097
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Adenosine A2a receptor agonist
UK432097
×
Maximum Phase:
2
First Approval:
None
UNII:
8L3OAJ1R5A
Molecule Type:
Small molecule
Molecular Formula:
C40H47N11O6
Molecular Weight:
777.89
AlogP:
1.92
PSA:
220.78
HBD:
7.0
HBA:
#RotB:
14.0
Source:
PRUVANSERIN
2
Small molecule
Investigational
Unknown
Unknown
Sleep Initiation and Maintenance Disorders
Serotonin 2a (5-HT2a) receptor antagonist
PRUVANSERIN
×
Maximum Phase:
2
First Approval:
None
UNII:
UL09X1D9EM
Molecule Type:
Small molecule
Molecular Formula:
C22H21FN4O
Molecular Weight:
376.44
AlogP:
3.18
PSA:
63.13
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RIPASUDIL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RIPASUDIL
×
Maximum Phase:
2
First Approval:
None
UNII:
11978226XX
Molecule Type:
Small molecule
Molecular Formula:
C15H18FN3O2S
Molecular Weight:
323.39
AlogP:
1.75
PSA:
62.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TARIBAVIRIN
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
TARIBAVIRIN
×
Maximum Phase:
2
First Approval:
None
UNII:
R3B1994K2E
Molecule Type:
Small molecule
Molecular Formula:
C8H13N5O4
Molecular Weight:
243.22
AlogP:
-2.83
PSA:
150.5
HBD:
5.0
HBA:
#RotB:
3.0
Source:
TAPRENEPAG ISOPROPYL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Prostanoid EP2 receptor agonist
TAPRENEPAG ISOPROPYL
×
Maximum Phase:
2
First Approval:
None
UNII:
81LDP7XIYG
Molecule Type:
Small molecule
Molecular Formula:
C27H28N4O5S
Molecular Weight:
520.61
AlogP:
3.99
PSA:
103.62
HBD:
0.0
HBA:
#RotB:
11.0
Source:
LOMIBUVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Hepatitis C virus NS5B RNA-dependent RNA polymerase negative allosteric modulator
LOMIBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
37L2LF4A2D
Molecule Type:
Small molecule
Molecular Formula:
C25H35NO4S
Molecular Weight:
445.63
AlogP:
5.31
PSA:
77.84
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PUMOSETRAG
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux; Irritable Bowel Syndrome
Unknown
PUMOSETRAG
×
Maximum Phase:
2
First Approval:
None
UNII:
1G26B32139
Molecule Type:
Small molecule
Molecular Formula:
C15H17N3O2S
Molecular Weight:
303.39
AlogP:
1.41
PSA:
65.2
HBD:
2.0
HBA:
#RotB:
2.0
Source:
LIAFENSINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder
Monoamine transporter inhibitor
LIAFENSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
R34ID086Z6
Molecule Type:
Small molecule
Molecular Formula:
C24H22N4
Molecular Weight:
366.47
AlogP:
4.46
PSA:
55.04
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PERZINFOTEL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Glutamate [NMDA] receptor antagonist
PERZINFOTEL
×
Maximum Phase:
2
First Approval:
None
UNII:
FX5AUU7Z8T
Molecule Type:
Small molecule
Molecular Formula:
C9H13N2O5P
Molecular Weight:
260.19
AlogP:
-0.92
PSA:
106.94
HBD:
3.0
HBA:
#RotB:
3.0
Source:
GR205171
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GR205171
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAMATASVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Nonstructural protein 5A inhibitor
SAMATASVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
21P699C5FC
Molecule Type:
Small molecule
Molecular Formula:
C47H48N8O6S2
Molecular Weight:
885.08
AlogP:
9.37
PSA:
174.64
HBD:
4.0
HBA:
#RotB:
11.0
Source:
AZD2423
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia; Pain; Pulmonary Disease, Chronic Obstructive
C-C chemokine receptor type 2 antagonist
AZD2423
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IBUTAMOREN MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Fibromyalgia
Ghrelin receptor agonist
IBUTAMOREN MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
R90JB6QJ2B
Molecule Type:
Small molecule
Molecular Formula:
C28H40N4O8S2
Molecular Weight:
624.78
AlogP:
1.77
PSA:
122.04
HBD:
2.0
HBA:
#RotB:
8.0
Source:
N-METHYL-D-ASPARTIC ACID (NMDA)
2
Small molecule
Investigational
Unknown
Unknown
Brain Injuries; Borderline Personality Disorder; Depressive Disorder, Major
Unknown
N-METHYL-D-ASPARTIC ACID (NMDA)
×
Maximum Phase:
2
First Approval:
None
UNII:
1903B9Q6PI
Molecule Type:
Small molecule
Molecular Formula:
C5H9NO4
Molecular Weight:
147.13
AlogP:
-0.87
PSA:
86.63
HBD:
3.0
HBA:
#RotB:
4.0
Source:
UPADACITINIB TARTRATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UPADACITINIB TARTRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
7KCW9IQM02
Molecule Type:
Small molecule
Molecular Formula:
C21H33F3N6O11
Molecular Weight:
602.52
AlogP:
2.91
PSA:
78.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
DOTANOC
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DOTANOC
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALSACLIDINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Muscarinic acetylcholine receptor M1 agonist
TALSACLIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
1O8VSL798T
Molecule Type:
Small molecule
Molecular Formula:
C10H15NO
Molecular Weight:
165.24
AlogP:
0.73
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
2.0
Source:
JNJ-26489112
2
Small molecule
Investigational
Unknown
Unknown
Epilepsy, Reflex
Unknown
JNJ-26489112
×
Maximum Phase:
2
First Approval:
None
UNII:
G1TI012DLT
Molecule Type:
Small molecule
Molecular Formula:
C9H11ClN2O4S
Molecular Weight:
278.72
AlogP:
0.27
PSA:
90.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
CHLOROGENIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Lung Neoplasms; Neoplasms; Glioblastoma; Glucose Intolerance
Unknown
CHLOROGENIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
318ADP12RI
Molecule Type:
Small molecule
Molecular Formula:
C16H18O9
Molecular Weight:
354.31
AlogP:
-0.65
PSA:
164.75
HBD:
6.0
HBA:
#RotB:
4.0
Source:
LIDORESTAT
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies
Unknown
LIDORESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
R3734K0M7L
Molecule Type:
Small molecule
Molecular Formula:
C18H11F3N2O2S
Molecular Weight:
376.36
AlogP:
4.34
PSA:
55.12
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GPX-100
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GPX-100
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOLASTATIN 10
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DOLASTATIN 10
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETIOPURPURIN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ETIOPURPURIN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C37H44N4O2
Molecular Weight:
576.79
AlogP:
8.81
PSA:
83.66
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BECOCALCIDIOL
2
Small molecule
Investigational
Unknown
Unknown
Psoriasis
Vitamin D receptor agonist
BECOCALCIDIOL
×
Maximum Phase:
2
First Approval:
None
UNII:
N75R59YD0F
Molecule Type:
Small molecule
Molecular Formula:
C23H36O2
Molecular Weight:
344.54
AlogP:
5.17
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
3.0
Source:
APD371
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
APD371
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACORAFLOXACIN HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Infections; Pneumonia, Bacterial
Unknown
ACORAFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
1NWW5SKQ0N
Molecule Type:
Small molecule
Molecular Formula:
C21H24ClF2N3O4
Molecular Weight:
455.89
AlogP:
2.96
PSA:
97.79
HBD:
2.0
HBA:
#RotB:
5.0
Source:
UPRIFOSBUVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Unknown
UPRIFOSBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
JW31KPS26S
Molecule Type:
Small molecule
Molecular Formula:
C22H29ClN3O9P
Molecular Weight:
545.91
AlogP:
1.93
PSA:
158.18
HBD:
3.0
HBA:
#RotB:
10.0
Source:
AZD-4877
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms
Kinesin-like protein 1 inhibitor
AZD-4877
×
Maximum Phase:
2
First Approval:
None
UNII:
19ORU63E06
Molecule Type:
Small molecule
Molecular Formula:
C28H33N5O2S
Molecular Weight:
503.67
AlogP:
4.71
PSA:
94.11
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PHENCYNONATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PHENCYNONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H84F112WBJ
Molecule Type:
Small molecule
Molecular Formula:
C22H31NO3
Molecular Weight:
357.49
AlogP:
3.34
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GSK-232802
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-232802
×
Maximum Phase:
2
First Approval:
None
UNII:
AG92SGO434
Molecule Type:
Small molecule
Molecular Formula:
C24H28O3
Molecular Weight:
364.49
AlogP:
6.13
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
1
2
…
128
129
130
131
132
133
134
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA